- Home
- ARWR vs FLOC Comparison
ARWR vs FLOC Comparison
Compare ARWR & FLOC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARWR
- FLOC
- Stock Information
- Founded
- ARWR 2003
- FLOC 1996
- Country
- ARWR United States
- FLOC United States
- Employees
- ARWR N/A
- FLOC N/A
- Industry
- ARWR Biotechnology: Pharmaceutical Preparations
- FLOC Metal Fabrications
- Sector
- ARWR Health Care
- FLOC Industrials
- Exchange
- ARWR Nasdaq
- FLOC Nasdaq
- Market Cap
- ARWR 1.8B
- FLOC 1.7B
- IPO Year
- ARWR 1993
- FLOC 2025
- Fundamental
- Price
- ARWR $13.03
- FLOC $22.68
- Analyst Decision
- ARWR Buy
- FLOC Strong Buy
- Analyst Count
- ARWR 11
- FLOC 5
- Target Price
- ARWR $41.44
- FLOC $33.60
- AVG Volume (30 Days)
- ARWR 1.6M
- FLOC 272.8K
- Earning Date
- ARWR 05-12-2025
- FLOC 05-13-2025
- Dividend Yield
- ARWR N/A
- FLOC 0.35%
- EPS Growth
- ARWR N/A
- FLOC N/A
- EPS
- ARWR N/A
- FLOC 10.41
- Revenue
- ARWR $2,500,000.00
- FLOC $535,278,000.00
- Revenue This Year
- ARWR $4,380.43
- FLOC $58.16
- Revenue Next Year
- ARWR $64.24
- FLOC $12.91
- P/E Ratio
- ARWR N/A
- FLOC $2.17
- Revenue Growth
- ARWR N/A
- FLOC 119.99
- 52 Week Low
- ARWR $9.57
- FLOC $16.69
- 52 Week High
- ARWR $30.41
- FLOC $30.50
- Technical
- Relative Strength Index (RSI)
- ARWR 47.38
- FLOC N/A
- Support Level
- ARWR $12.44
- FLOC N/A
- Resistance Level
- ARWR $14.97
- FLOC N/A
- Average True Range (ATR)
- ARWR 0.74
- FLOC 0.00
- MACD
- ARWR 0.11
- FLOC 0.00
- Stochastic Oscillator
- ARWR 37.01
- FLOC 0.00
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.
About FLOC Flowco Holdings Inc. Class A Common Stock
Flowco Holdings Inc is a provider of production optimization, artificial lift and methane abatement solutions for the oil and natural gas industry. Its technologies include high pressure gas lift (HPGL), conventional gas lift, plunger lift and vapor recovery unit (VRU) solutions. The company operates in two reportable segments: Production Solutions which include rental services and Natural Gas Technologies which include service gas compression parts and equipment sales. Production Solutions: relates to rentals, sales and services related to high pressure gas lift, conventional gas lift and plunger lift; including other digital solutions and methane abatement technologies, and has maximum revenue.